Skip to main content
BMJ Open logoLink to BMJ Open
. 2020 Oct 10;10(10):e040437. doi: 10.1136/bmjopen-2020-040437

Utilisation of health services among urban patients who had an ischaemic stroke with different health insurance - a cross-sectional study in China

Yong Yang 1,#, Xiaowei Man 1,#, Stephen Nicholas 2,3,4,5, Shuo Li 1, Qian Bai 1, Lieyu Huang 1, Yong Ma 6, Xuefeng Shi 1,7,
PMCID: PMC7549448  PMID: 33040017

Abstract

Objectives

This study investigates the disparities in the utilisation of patient health services for patients who had a stroke covered by different urban basic health insurance schemes in China.

Design

We conducted descriptive analysis based on a 5% random sample from claims data of China Urban Employees’ Basic Medical Insurance (UEBMI) and Urban Residents’ Basic Medical Insurance (URBMI) in 2015, supplied by the China Health Insurance Research Association.

Setting

Chinese urban social insurance system.

Participants

A total of 56 485 patients who had a stroke were identified, including 36 487 UEBMI patients and 19 998 URBMI patients.

Primary and secondary outcome measures

The primary outcome measures include annual number of hospitalisations, average length of stay (ALOS) and average hospitalisation cost. Out-of-pocket (OOP) cost is the secondary outcome measure.

Results

The annual mean number of hospitalisations of UEBMI patients was 1.21 and 1.15 for URBMI patients. The ALOS was significantly longer for UEBMI than for URBMI patients (13.93 vs 10.82, p<0.001). Hospital costs were significantly higher for UEBMI than for URBMI patients (US$1724.02 vs US$986.59 (p<0.001), while the OOP costs were significantly higher for URBMI than for UEBMI patients (US$423.17 vs US$407.81 (p<0.001). Patients with UEBMI had higher reimbursement rate than URBMI patients (79.41% vs 66.92%, p<0.001) and a lower self-paid ratio than URBMI patients (23.65% vs 42.89%, p<0.001).

Conclusions

Significant disparities were found in the utilisation of hospital services between UEBMI and URBMI patients. Our results call for a systemic strategy to improve the fragmented social health insurance system and narrow the gaps in China’s health insurance schemes.

Keywords: health policy, public health, health economics, stroke


Strengths and limitations of this study.

  • A large scale cross-sectional investigation of disparities in healthcare utilisation of patients with ischaemic strokebetween different health insurance schemes in urban China.

  • Detailed data on the mean number of hospitalisations, average length of stay and hospital costs.

  • Our comparisons were based on the utilisation of health services and hospital costs, but clinical outcomes were not examined

  • Our sample included urban residents only, therefore our results may be not apply to rural residents.

  • Out-of-pocket expenses by insurance scheme used as a secondary outcome measure.

Introduction

Expanding health insurance coverage is the main approach to strengthen household financial protection from poor health and to improve healthcare accessibility.1 2 In 2005, the WHO encouraged its members to achieve the universal health coverage (UHC) goal that all people obtain good-quality essential health services, including promotion, prevention, treatment, rehabilitation and palliation, without enduring financial hardship.3 In response, many countries, including China, have taken effective measures to expand their health coverage. In the process of achieving the UHC goals, low-level insurance coverage and disparities between social health insurance schemes were identified as major issues hindering equity in healthcare access.4 5 Health services utilisation has been considered as one of the important elements of health equity.6

Over the past decade, China’s health insurance system has improved significantly, with the insured rate increasing from 89.25% in 2009 to over 95% in 2011. Today, more than 1.35 billion Chinese people are covered by basic medical insurance.7 Before 2015, there were two main health insurance schemes for urban residents in China: the Urban Residents’ Basic Medical Insurance (URBMI) scheme for the unemployed, retired, students and children, and Urban Employees’ Basic Medical Insurance (UEBMI) scheme for employed urban workers.8 However, wide gaps existed between the different health insurance schemes. The main disparities lay in the targeted population, source of funding, funding level and administration and benefit packages.9 10 Some of these differences caused inequity in healthcare utilisation10 11 and imposed differential financial burdens on households.11 Researchers have analysed the disparities in healthcare utilisation under these two different health insurance schemes from the perspective of certain diseases. For example, patients with mental illness covered by urban insurance schemes accessed hospitals more than rural insured patients12 and UEBMI tuberculosis patients had higher utilisation rates than their URBMI counterparts.13 We know little about the disparities in hospital utilisation rates for other diseases. Although stroke is the most common cause of death in China, there is a paucity of research about the utilisation of stroke inpatient services under China’s different health insurance schemes. For insured patients who had an ischaemic stroke, we investigated how the two basic urban insurance schemes cause inequities in healthcare utilisation and exposed households to different financial risks from medical expenses.

Materials and methods

Data sources

From the population of all UEBMI and URBMI payments in China, a 5% random sample of the medical information for each ischaemic stroke beneficiary was collected in 2015, including age, date of visit, health institute name, primary diagnosis (classified according to International Classification of Diseases, 10th edition (ICD-10)), city of residence, cost per inpatient treatment (including out-of-pocket (OOP) expenses) and length of hospital stay (LOS).

Indicators

The annual number of hospitalisations, average length of stay (ALOS) and average hospitalisation cost of patients who had an ischaemic stroke were the three indicators of inpatient healthcare services utilisation.14–16 Among them, hospitalisation cost could be divided into three parts: compensation fee, OOP cost within insurance and OOP expense outside insurance.

The compensation fee was compensated by the health insurance scheme when patients used health services covered in basic medical insurance reimbursement directory. The OOP cost within insurance refers to expense paid by patients when consuming healthcare covered in the directory. While the OOP cost outside insurance was also paid by patients due to consumption of health services not covered by the directory. All costs were adjusted according to the average annual 2015 US$–RMB exchange rate: US$1.0=RMB6.2284.

Methods

Individual patients who had a stroke were divided into different groups according to factors that impacted their utilisation of inpatient health services.17 Using ICD-10, ischaemic stroke types were defined by I63, I63.0–5 (cerebral infarction due to thrombosis of precerebral arteries, embolism of precerebral arteries, unspecified occlusion or stenosis of precerebral arteries), I63.8 and I63.9 (other and unspecified cerebral infarction). Based on bed size, location and functional orientation, hospitals in China were divided into primary hospitals, with less than 100 beds, providing basic health services to residents in a community; secondary hospitals, with 100–500 beds, providing comprehensive health services to several communities as well as medical training and regional-based research and tertiary hospitals, with over 500 beds, providing complex healthcare for several districts and undertaking advanced medical education and research.

Table 1 provides an overview comparing the differences between the UEBMI and URBMI: UEBMI offers compulsory, comprehensive insurance for employed people with a per capita fund of RMB3144 (US$505) in 2015, based on contributions from employers and employees, with an 80% reimbursement rate and basic urban wage reimbursement ceiling; URBMI is voluntary, offering limited insurance to unemployed urban residents, with a per capita fund of RMB560 (US$90) in 2015, based on a government subsidy and individual premiums, with a 70% reimbursement rate and farmer income-based reimbursement ceiling.

Table 1.

Comparison of medical insurance schemes for urban residents in China

URBMI UEBMI
Inception year 2007 1998
Eligible population Children, students, older people, people with disabilities, other non-working urban residents Urban, employed
Enrolment type Voluntary Compulsory
Number of people insured 377 million 289 million
Source of funding Government subsidy (RMB380) and individual premium (varied by locations) Contributory (8% of annual wage, 6% from employers and 2% from employees)
Per-capita fund RMB560 RMB3144
Benefit package Inpatient and catastrophic outpatient medical service Outpatient and inpatient medical service
General outpatient services Limited and varied by locations Comprehensive
Rate of reimbursement (inpatient) Over 80%, varies across cities/counties About 70%, varies across cities/counties
Annual reimbursement
ceiling
Six times income of local farmers Six times average wage of employee in the city
Demand for payment Once a year, always 25 years for men, 20 years for women, have no more need of contributions after retirement

Data source: 2015 National Health Statistics Annual Report.

UEBMI, Urban Employee Basic Medical Insurance; URBMI, Urban Resident Basic Medical Insurance.

According to the economic development level and geographical location, we divided our hospitals into three regions: east, central and west. In terms of economic development level and medical resources, industrialised eastern China had a per capita disposable income of RMB28223.3 (US$4531.4); the less developed central region had a per capita disposable income of RMB18442.1 (US$2961.0) and the mainly agricultural and underdeveloped western region had a per capita disposable income of RMB16868.1 (US$2708.3).18 Descriptive analysis was used to report the demographic information and all outcome indicators on patients. Since the number of hospitalisations, ALOS and hospitalisation costs data had a skewed distribution, we adopted Mann-Whitney test to identify whether the differences in patients’ utilisation of inpatient health and OOP costs of these two health insurance schemes were statistically significant. Linear regression was employed to assess the impact of insurance type on healthcare utilisation and hospital costs.19 A p value of less than 0.05 was considered statistically significant. All statistical calculations were performed using STATA V.15.0.

Results

Basic information of sample

As shown in table 2, a total of 56 485 patients who had an ischaemic stroke were included in our analysis, of whom 64.60% (36 487) were covered by UEBMI and 35.40% (19 998) were covered by URBMI. The average age of UEBMI patients was 68.64 years and URBMI patients was 67.45 years; nearly half of the patients (47.68%) choose secondary hospitals to have their medical treatment and 32.65% (18 443) sought medical treatment in tertiary hospitals and 46.36% (26 184) of the patients were in hospital in the central China, 36.91% (20 850) in the east and 16.73% (9451) in the western region. Compared with URBMI members, UEBMI members were more likely to be admitted to tertiary hospitals (41.24% vs 16.96%) and less likely to be admitted to primary health facilities (12.95% vs 31.93%).

Table 2.

Sample descriptive statistics

Overall number (%) UEBMI number (%) URBMI number (%) P value
Sex <0.001
 Male 32 658 (57.82) 23 445 (64.26) 9213 (46.07)
 Female 23 827 (42.18) 13 042 (35.74) 10 785 (53.93)
Age (years)
 Mean±SD 68.22±11.12 68.64±11.06 67.45±11.20
Age group <0.001
 0–44 1222 (2.16) 789 (2.16) 433 (2.17)
 45–59 10 825 (19.16) 6694 (18.35) 4131 (20.66)
 ≥60 44 438 (78.67) 29 004 (79.49) 15 434 (77.18)
ICD code <0.001
 I63 472 (0.84) 446 (1.22) 26 (0.13)
 I63.0 5 (0.01) 3 (0.01) 2 (0.01)
 I63.1 4 (0.01) 2 (0.01) 2 (0.01)
 I63.2 14 (0.02) 11 (0.03) 3 (0.02)
 I63.3 41 (0.07) 31 (0.08) 10 (0.05)
 I63.4 45 (0.08) 25 (0.07) 20 (0.1)
 I63.5 54 (0.10) 25 (0.07) 29 (0.15)
 I63.8 78 (0.14) 75 (0.21) 3 (0.02)
 I63.9 55 772 (98.74) 35 869 (98.31) 19 903 (99.52)
Hospital level <0.001
 Primary 11 110 (19.67) 4725 (12.95) 6385 (31.93)
 Secondary 26 932 (47.68) 16 713 (45.81) 10 219 (51.1)
 Tertiary 18 443 (32.65) 15 049 (41.24) 3394 (16.97)
Region <0.001
 East 20 850 (36.91) 13 960 (38.26) 6890 (34.45)
 Central 26 184 (46.36) 17 116 (46.91) 9068 (45.34)
 West 9451 (16.73) 5411 (14.83) 4040 (20.2)

I63, I63.0–5 (cerebral infarction due to thrombosis of precerebral arteries, embolism of precerebral arteries, unspecified occlusion or stenosis of precerebral arteries), I63.8 and I63.9 (other and unspecified cerebral infarction).

UEBMI, Urban Employees’ Basic Medical Insurance; URBMI, Urban Residents’ Basic Medical Insurance.

Utilisation of inpatient health services for patients who had a stroke

The utilisation of patient health services for all insured, UEBMI and URBMI patients are described in table 3 by the number of hospitalisations and in table 4 by ALOS. The annual number of hospitalisations among UEBMI patients was greater than those covered by URBMI (1.21 vs 1.15; p<0.001). Further, the higher annual number of hospitalisations of UEBMI patients compared with URBMI patients differed significantly (p<0.001) according to sex and hospital level. In addition, there were statistically significant differences (p<0.001) in the ALOS between UEBMI patients and URBMI patients according to sex, age group, hospital levels and region. For example, ALOS for patients with UEBMI was 13.92 days, significantly longer than patients with URBMI patients with 10.82 days (p<0.001).

Table 3.

The annual number of hospitalisations of patients who had an ischaemic stroke

Overall (mean±SD) UEBMI (mean±SD) URBMI (mean±SD) P value
Sex
 Male 1.21±0.67 1.23±0.72 1.17±0.52 <0.001
 Female 1.16±0.53 1.18±0.59 1.14±0.46 <0.001
Age group
 0–44 1.17±0.61 1.20±0.70 1.12±0.43 0.050
 45–59 1.17±0.55 1.18±0.59 1.15±0.48 0.009
 ≥60 1.2±0.63 1.22±0.69 1.15±0.49 <0.001
ICD code
 I63 1.38±0.82 1.38±0.81 1.44±1.03 0.773
 I63.0 1.19±0.58 1.21±0.65 1.14±0.45 <0.001
 I63.1 1.00±0.00 1.00±0.00 1.00±0.00
 I63.2 1.33±0.49 1.33±0.52 1.33±0.52 1.000
 I63.3 1.24±0.60 1.29±0.69 1.13±0.35 0.521
 I63.4 1.23±0.67 1.81±0.50 1.33±1.00 0.580
 I63.5 1.30±0.78 1.20±0.70 1.41±0.87 0.416
 I63.8 1.24±0.87 1.37±1.05 1.00±0.00 0.037
 I63.9 1.19±0.62 1.21±0.68 1.15±0.49 <0.001
Hospital level
 Primary 1.22±0.67 1.29±0.84 1.18±0.53 <0.001
 Secondary 1.17±0.57 1.20±0.63 1.14±0.45 <0.001
 Tertiary 1.2±0.64 1.21±0.67 1.15±0.52 <0.001
Region
 East 1.25±0.77 1.28±0.86 1.19±0.57 <0.001
 Central 1.19±0.55 1.19±0.56 1.18±0.51 0.177
 West 1.07±0.37 1.11±0.45 1.03±0.20 <0.001

P values are based on Mann-Whitney test; I63, I63.0–5 (cerebral infarction due to thrombosis of precerebral arteries, embolism of precerebral arteries, unspecified occlusion or stenosis of precerebral arteries), I63.8 and I63.9 (other and unspecified cerebral infarction).

Table 4.

The average length of stay of patients who had a stroke

Overall (mean±SD) UEBMI (mean±SD) URBMI (mean±SD) P value
Sex
 Male 13.16±13.22 14.04±14.03 10.91±10.55 <0.001
 Female 12.38±11.57 13.73±13.40 10.75±8.57 <0.001
Age group
 0–44 12.73±9.89 13.66±10.99 11.01±8.17 <0.001
 45–59 11.83±9.08 12.41±9.24 10.91±8.72 <0.001
 ≥60 13.08±13.32 14.29±14.70 10.80±9.78 <0.001
ICD code
 I63 29.2±41.26 28.81±40.48 35.85±53.49 0.399
 I63.0 9.00±4.90 9.00±3.46 9.00±8.49 1.000
 I63.1 8.00±4.69 8.50±2.10 7.50±7.78 0.887
 I63.2 8.57±5.29 9.00±5.90 7.00±1.00 0.582
 I63.3 20.00±13.60 22.39±14.73 12.60±4.27 0.002
 I63.4 12.24±6.35 14.48±7.43 9.45±3.00 0.004
 I63.5 10.15±4.46 12.08±4.84 8.48±3.78 0.002
 I63.8 15.33±13.69 15.55±13.92 10.00±2.65 0.495
 I63.9 12.69±11.94 13.74±14.05 10.80±9.32 <0.001
Hospital level
 Primary 12.43±17.67 16.12±21.19 9.71±8.64 <0.001
 Secondary 12.45±10.95 13.25±11.67 11.13±9.54 <0.001
 Tertiary 13.63±10.89 13.99±11.22 12.00±9.11 <0.001
Region
 East 13.85±14.98 15.09±16.31 11.34±11.44 <0.001
 Central 12.16±9.73 12.90±10.50 10.76±7.89 <0.001
 West 12.45±13.46 14.21±15.64 10.10±9.30 <0.001

All values mean±SD; p values are based on Mann-Whitney test; I63, I63.0–5 (cerebral infarction due to thrombosis of precerebral arteries, embolism of precerebral arteries, unspecified occlusion or stenosis of precerebral arteries), I63.8 and I63.9 (other and unspecified cerebral infarction).

UEBMI, Urban Employees’ Basic Medical Insurance; URBMI, Urban Residents’ Basic Medical Insurance.

Table 5 shows that the UEBMI inpatient hospital costs were significantly higher than the URBMI group, which differed significantly according to sex, age group, hospital level and region (all p<0.001). Overall, the mean total hospitalisation costs in the UEBMI group was RMB11187.64 (US$1724.02), significantly higher than that in URBMI group (RMB6402.27 (US$986.59)).

Table 5.

The average hospitalisation costs of patients who had an ischaemic stroke

Overall (mean±SD) UEBMI (mean±SD) URBMI (mean±SD) P value
Sex
 Male 10 044.32±15 342.08 11 446.85±16 772.79 6475.18±10 036.24 <0.001
 Female 8738.35±12 619.51 10 357.79±14 199.52 6339.98±9874.92 <0.001
Age group
 0–44 10 957.67±18 029.09 13 070.86±21 403.27 7454.93±11 482.54 <0.001
 45–59 8926.78±12 728.84 10 332.90±13 376.31 6647.08±11 197.23 <0.001
 ≥60 9591.19±14 503.57 11 338.85±16 271.26 6307.21±9537.80 <0.001
ICD Code
 I63 14 618.74±12 019.24 14 640.77±12 189.20 14 240.85±8766.05 0.869
 I63.0 6072.54±6710.57 7305.14±8994.47 4223.64±2632.68 0.683
 I63.1 3190.43±1495.48 3236.72±2277.72 3144.13±1229.97 0.965
 I63.2 22 449.77±32 781.83 26 855.59±35 921.04 6295.09±5948.70 0.356
 I63.3 19 720.70±20 259.93 22 146.59±22 657.40 12 200.43±5475.93 0.180
 I63.4 7444.69±5952.03 10 059.32±6047.21 4176.41±3950.90 <0.001
 I63.5 4224.79±3402.90 6158.34±3093.81 2557.94±2738.39 <0.001
 I63.8 15 161.85±12 034.31 15 444.78±12 163.95 8088.81±4808.19 0.302
 I63.9 9438.86±14 277.7 11 126.59±15 935.67 6397.26±9959.84 <0.001
Hospital level
 Primary 4297.96±8332.55 6352.05±11 513.58 2777.91±3480.63 <0.001
 Secondary 7776.65±9880.66 8569.51±10 781.67 6479.96±8029.87 <0.001
 Tertiary 15 130.12±19 674.80 15 613.53±20 146.07 12 986.70±17 272.8 <0.001
Region
 East 11 881.32±15 794.28 13 687.18±16 850.91 8222.43±12 633.44 <0.001
 Central 7836.13±12 946.00 9153.79±14 761.89 5349.01±7948.55 <0.001
 West 8816.99±13 492.20 11 172.47±15 959.32 5662.16±8208.23 <0.001

P values are based on Mann-Whitney test; all costs were based on a constant 2015 RMB; I63, I63.0–5 (cerebral infarction due to thrombosis of precerebral arteries, embolism of precerebral arteries, unspecified occlusion or stenosis of precerebral arteries), I63.8 and I63.9 (other and unspecified cerebral infarction).

Composition of average total hospitalisation costs

Table 6 describes the composition of average total hospitalisation costs per patient for each insurance type. Insurance only covered 62.87% of URBMI patient total hospital costs, but 75.72% of UEBMI patients. While patients with UEBMI had lower average total OOP expenses (RMB2646.42/US$407.81) than those with URBMI (RMB2746.10/US$423.17), UEBMI patients had much higher average total hospitalisation costs (RMB11187.64/US$1724.02) than URBMI patients (RMB6402.27/US$986.61). This difference in OOP expenses was mainly due to the different reimbursement rates for hospitalisation costs, which were 79.41% for UEBMI, but only 66.92% for URBMI, patients as set out in the different benefit packages in table 1. Table 6 explores these OOP expenses, which shows that patients with UEBMI had fewer OOP costs within insurance (RMB1793.35/US$276.36) than URBMI patients (RMB2072.85/US$319.43), due to the significantly higher rate of hospital cost coverage by insurance. While UEBMI patients had higher OOP cost (RMB853.06/US$128.43) outside insurance than patients with URBMI (RMB673.24/US$101.36), which means UEBMI beneficiaries consumed more health services not covered by their health insurance scheme. However, UEBMI patients had significantly lower self-paid rate (23.65%) than URBMI patients (42.89%).

Table 6.

Composition of mean total hospitalisation costs (RMB)

Overall UEBMI URBMI P value
Number 56 485 36 487 19 998
Hospitalisation cost (RMB) 9493.42 11 187.64 6402.27 <0.001
Compensation fee 6811.96 8541.69 3656.17 <0.001
Reimbursement rate (%) 74.84 79.41 66.92 <0.001
Cover rate (%) 71.01 75.72 62.87 <0.001
Total OOP cost (RMB) 2681.71 2646.42 2746.10 <0.001
OOP within insurance 1892.31 1793.35 2072.85 <0.001
OOP outside insurance 789.40 853.06 673.24 <0.001
Self-paid ratio 23.65% 42.89% <0.001

All costs were based on a constant 2015 RMB; p values were based on the Mann-Whitney test; reimbursement rate=compensation fee/(ccompensation fee+OOP within insurance); cover rate=compensation fee/hospitalisation cost; self-paid ratio refers to the total OOP costs as a proportion of the hospitalisation costs.

OOP, out of pocket.

The impact of insurance type on patients’ healthcare utilisation

Table 7 shows the impact of insurance type on patients’ healthcare utilisation. Adjusted for age, sex, region and hospital level, UEBMI patients significantly (p<0.001) used more healthcare services and had higher hospital costs than URBMI patients.

Table 7.

The impact of insurance type on patients’ healthcare utilisation

Characteristics Patient visit Length of stay Hospital costs
Coef. Std. err. P value Coef. Std. err. P value Coef. Std. err. P value
Insurance type (Ref: UEBMI)
 URBMI −0.025 0.003 <0.001 −0.191 0.006 <0.001 −0.289 0.007 <0.001
 Constant <0.001 <0.001 <0.001
 R2 (adjusted) 0.018 0.041 0.350

All models were adjusted for gender, age, region and hospital level.

UEBMI, Urban Employees’ Basic Medical Insurance; URBMI, Urban Residents’ Basic Medical Insurance.

Discussion

In China, the prevalence of stroke has increased at a rate of nearly 9% per year, with a high proportion in high-risk groups.20 21 Ischaemic stroke was the most common type of stroke.22 To our knowledge, this is the first study using a large nation-wide Chinese health insurance claims database to explore disparities in the healthcare utilisation of patients with ischaemic stroke health services under two different urban basic health insurances schemes. Our study revealed that the UEBMI group used significantly more health services and had significantly higher hospital costs than the URBMI group. Compared with URBMI patients, UEBMI patients had 1.21 versus 1.15 annual number of hospitalisations, 13.93 days versus 10.82 days ALOS and RMB11187.64 (US$1724.02) versus RMB 6402.27 (US$1027.87) average hospitalisation costs.

Patients who had a stroke with UEBMI had lower OOP costs for within insurance coverage, but higher OOP costs for outside insurance coverage, than patients with URBMI. The explanation is related to the disparity in reimbursement rates, which are illustrated in table 1.23 The source and level of within insurance reimbursements reflect different financing for UEBMI and URBMI, which affects the amount of funds available for patients and results in different reimbursement levels and anti-risk capacity.24 Also, higher reimbursement rates meant lower OOP expenditures, leading patients to consume more and better health services.25 The OOP expenses for outside insurance packages were higher for the UEBMI group than the URBMI group. Patients covered by UEBMI generally have stable jobs and higher incomes, and this endowed them greater capacity and willingness to pay for additional health services.6 Our data show that UEBMI patients were more likely to be treated at a tertiary hospital, and less likely to attend a primary hospital, than URBMI patients. Patients treated in tertiary hospitals were more likely to be prescribed expensive medicines, which fell outside the reimbursement guidelines of their insurance packages.11

The higher annual number of hospitalisations of the UEBMI group was likely associated with the higher ability to pay for hospital expenses due to higher income. UEBMI members were likely to use inpatient services more, while URBMI members used more outpatient services, with lower OOP and hospital expenses.26 We speculate that patients covered by UEBMI had higher levels of education and socioeconomic status than URBMI members, as well as paying more attention to their personal health,27 which meant UEBMI members likely visited the hospital more frequently than URBMI members. Similarly, low socioeconomic status and poor education level have been found to be important influential factors that delay patients from seeking hospital services, which reduced both ALOS and OOP expenses.28

Government policies and incentives reflected in UEBMI and URBMI were also leading influencing factors in the ALOS,29 along with stroke type and stroke severity.30 An US study31 showed that the ALOS was significantly longer for patients who had a stroke with Medicaid than those with private insurance by more than 2 days. Under the protection of health insurance, cerebral infarction inpatients with higher financial support tended to increase their length of stay, although there may have been no medical need for more treatments.32 We predict that the different UEMBI–URBMI benefit packages impacted ALOS in our study.33

We also found that patients with UEBMI had higher hospitalisation costs, which is consistent with existing studies.34 Doctors’ behaviour towards UEBMI patients partly explain these higher costs. Depending on a patient’s health insurance status, different therapeutic schedules would be considered by doctors, which could result in different effectiveness of stroke treatment.35 Additionally, supply-induced demand may influence the behaviour of doctors. One study found that under the influence of supply-induced demand, a higher benefit level for a health insurance scheme was associated with a stronger impact on total medical expenses.36 There may also have been a hyper demand for medical treatment. UEBMI patients may have demanded more treatment, especially drugs, given the benefit package and the reimbursement rates of the UEBMI scheme.

In contrast to UEBMI patients, URBMI patients incurred lower hospitalisation costs. One possible explanation is that URBMI members were mainly urban unemployed and the elderly without pension, who were not in a strong financial protection to afford high hospitalisation costs. URBMI patients were more likely to forgo the same level of health services as UEBMI patients.37 Facing possible catastrophic health expenditure, URBMI members may have reduced the use of health services, stayed in hospital for a shorter time and reduced drugs, tests and treatment compared with UEBMI members. We speculate that the high economic burden of hospital inpatient treatment meant some URBMI members, with low family incomes or unemployed, reduced the amount of inpatient treatment, or sought outpatient instead of inpatient treatment or gave up visiting hospitals.38

Differences in the sample characteristics also impacted our results. The UEBMI scheme covered more male patients, while the URBMI scheme covered more female patients. Males have a higher probability of having stroke and incur higher healthcare costs than females.39 40 Regarding age, younger patients who had a stroke had higher hospitalisation costs in the URBMI subgroup, since URBMI was targeted at children, students and the non-working young, a result consistent with previous studies.41 42 However, in the UEBMI subgroups, patients over 60 years incurred higher hospitalisation costs than those between 45 and 59 years. In the URBMI subgroup, patients over 60 years had lower hospitalisation costs than those between 45 and 59 years. One explanation is that patients over 60 years covered by UEBMI had a stable retirement salary, their financial status was better than their peers covered by URBMI scheme, which led them to consume more health services.43 Most importantly, higher hospitalisation costs were strongly related to longer length of stay,44 45 with UEBMI patients having longer length of stays, and therefore higher hospitalisation costs, than URBMI patients.

In order to improve China’s fragmented social health insurance system and narrow the gap in health insurance schemes, the government officially launched the medical security system for URBMI urban and rural residents in 2016.46 The gap between urban and rural residents in terms of contribution levels, financial subsidies and treatment was narrowed.47 Nevertheless, the disparities between urban–rural resident medical insurance and UEBMI remains. This strongly suggests that the further consolidation of China’s social health insurance schemes is required to address access and equity in healthcare services. The key challenges are to unite the funding levels, cost-sharing methods, standards of payment systems and service provisions of the different insurance schemes.8 Meeting these challenges can play a positive role in improving health equity. To bridge the UEBMI–URBMI gap in healthcare utilisation, we recommend the government to launch a new critical illness contributory insurance scheme covering severe diseases, such as stroke. Given differentials in family income between urban and rural residents and across cities and geographical regions, national government insurance reforms would be required. An independent risk pool of the new critical illness contributory insurance scheme could be expanded from city and prefecture level to a larger risk pool at national level. Protected by the same risk pool, residents would enjoy the same insurance welfare and economic protection, which may effectively reduce the geographical inequity in stroke patients’ healthcare utilisation and expenditure. The new critical illness insurance should also set higher reimbursement rates and reimbursement cap lines, to protect patients from catastrophic health expenditure.

This study has several limitations. First, we did not examine clinical outcomes of stroke, (eg, mortality, complications, quality of life) between the two insurance schemes although different hospitalisation rates/LOS may lead to different clinical outcomes. Second, only urban residents were included in this study, our results could not reflect utilisation and expenses of rural patients who had a stroke. Third, due to lack of data, we do not know details of hospital costs for patients who had a stroke, such as fees for medical check, surgery and drug; thus, we cannot assess what health services have contributed to hospital costs most.

Conclusion

Large disparities existed between UEBMI and URBMI members’ utilisation of ischaemic stroke health services in China, with UEBMI providing better financial support for medical expenses and lower OPP expenses. The reimbursement ratio of the two urban health insurance schemes provides a crucial policy tool for addressing the utilisation of health services. Our findings suggest that consolidating the social health insurance schemes to the higher UEBMI levels will reduce the economic burden on households caused by stroke and improve healthcare access and equity. Launching a new critical illness contributory insurance scheme covering severe diseases, such as stroke, would offer all residents a more equal access to healthcare services. These recommendations have international significance: stroke is a global disease, and effective health insurance measures are required to control it. Providing a valuable international reference point, this study identified the need for a comprehensive and integrated health insurance scheme, especially in countries where the health insurance system is fragmented.

Supplementary Material

Reviewer comments
Author's manuscript

Acknowledgments

We thank the support of the China Health Insurance Research Association, for providing the valuable data.

Footnotes

YY and XM contributed equally.

Author Contributions: While conducting this study, YY and XS developed the research aims, analysed the data and drafted the manuscript; XM and SL analysed the data and edited the manuscript; QB, LH and YM developed the research idea and helped interpreted the data analysis; SN wrote part of the draft and edited the manuscript; YM oversaw the data collection and XS collected the data, helped develop the idea and edited the manuscript.

Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

Competing interests: None declared.

Patient consent for publication: Not required.

Ethics approval: Since the claims data were an anonymised database and had no impact on patients’ health and care, the informed consent was exempted. This study was approved by the ethics committee of Beijing University of Chinese Medicine (No. 2019BZHYLL0201).

Provenance and peer review: Not commissioned; externally peer reviewed.

Data availability statement: The data were provided by China Health Insurance Research Association, and these are third party data. Authors in this study have the right to use this dataset, but not the right to share and distribute the data.

References

  • 1.Garcia-Subirats I, Vargas I, Mogollón-Pérez AS, et al. Barriers in access to healthcare in countries with different health systems. A cross-sectional study in municipalities of central Colombia and north-eastern Brazil. Soc Sci Med 2014;106:204–13. 10.1016/j.socscimed.2014.01.054 [DOI] [PubMed] [Google Scholar]
  • 2.Richardson E, Roberts B, Sava V, et al. Health insurance coverage and health care access in Moldova. Health Policy Plan 2012;27:204–12. 10.1093/heapol/czr024 [DOI] [PubMed] [Google Scholar]
  • 3.Boerma T, Eozenou P, Evans D, et al. Monitoring progress towards universal health coverage at country and global levels. PLoS Med 2014;11:e1001731. 10.1371/journal.pmed.1001731 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kazungu JS, Barasa EW, levels E. Examining levels, distribution and correlates of health insurance coverage in Kenya. Trop Med Int Health 2017;22:1175–85. 10.1111/tmi.12912 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Amu H, Dickson KS, Kumi-Kyereme A, et al. Understanding variations in health insurance coverage in Ghana, Kenya, Nigeria, and Tanzania: evidence from demographic and health surveys. PLoS One 2018;13:e0201833. 10.1371/journal.pone.0201833 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Liu X, Wong H, Liu K. Outcome-based health equity across different social health insurance schemes for the elderly in China. BMC Health Serv Res 2016;16:9. 10.1186/s12913-016-1261-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.China NHaFPCotPsRo More than 1.35 billion people have been covered by basic medical insurance,coverage of social security programs reached 95% in China, 2018. Available: http://news.china.com.cn/2018-02/12/content_50494717.htm
  • 8.Meng Q, Fang H, Liu X, et al. Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet 2015;386:1484–92. 10.1016/S0140-6736(15)00342-6 [DOI] [PubMed] [Google Scholar]
  • 9.Yip WC-M, Hsiao WC, Chen W, et al. Early appraisal of China's huge and complex health-care reforms. Lancet 2012;379:833–42. 10.1016/S0140-6736(11)61880-1 [DOI] [PubMed] [Google Scholar]
  • 10.Chen R, Li N-X, Liu X. Study on the equity of medical services utilization for elderly enrolled in different basic social medical insurance systems in an underdeveloped city of Southwest China. Int J Equity Health 2018;17:54. 10.1186/s12939-018-0765-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Feng Y, Xiong X, Xue Q, et al. The impact of medical insurance policies on the hospitalization services utilization of people with schizophrenia: a case study in Changsha, China. Pak J Med Sci 2013;29:793–8. 10.12669/pjms.293.3273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Xu J, Wang J, King M, et al. Rural-Urban disparities in the utilization of mental health inpatient services in China: the role of health insurance. Int J Health Econ Manag 2018;18:377–93. 10.1007/s10754-018-9238-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Pan Y, Chen S, Chen M, et al. Disparity in reimbursement for tuberculosis care among different health insurance schemes: evidence from three counties in central China. Infect Dis Poverty 2016;5:7. 10.1186/s40249-016-0102-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Garland AF, Lau AS, Yeh M, et al. Racial and ethnic differences in utilization of mental health services among high-risk youths. Am J Psychiatry 2005;162:1336–43. 10.1176/appi.ajp.162.7.1336 [DOI] [PubMed] [Google Scholar]
  • 15.Xu J, Wang J, Liu R, et al. Mental health inpatient treatment expenditure trends in China, 2005-2012: evidence from Shandong. J Ment Health Policy Econ 2014;17:173–82. [PubMed] [Google Scholar]
  • 16.Yi F, Xianjun X, Li X, et al. Service utilization analysis of inpatients with schizophrenia in different medical insurance in Shenzhen. Health Econ 2014;3:39–41. [Google Scholar]
  • 17.Zhang H, Sun Y, Zhang D, et al. Direct medical costs for patients with schizophrenia: a 4-year cohort study from health insurance claims data in Guangzhou City, southern China. Int J Ment Health Syst 2018;12:72. 10.1186/s13033-018-0251-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Yi Z, Yi-shan Y. Analysis of the distribution status and convergence path of health resources in China: based on provincial panel data. Chinese Health Economics;37:46–9. [Google Scholar]
  • 19.Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (cheers) statement. Eur J Health Econ 2013;14:367–72. 10.1007/s10198-013-0471-6 [DOI] [PubMed] [Google Scholar]
  • 20.Zhang D, Han L. Academician Wang longde on the current situation of stroke prevention and control in China. Camb Q Healthc Ethics 2011;1:3. [Google Scholar]
  • 21.Wang L. Report on stroke prevention and treatment in China : Chang J, Xunming J, Bin L, et al., Beijing: People’s Medical Publishing House, 2016: 113. [Google Scholar]
  • 22.Krishnamurthi RV, Barker-Collo S, Parag V, et al. Stroke incidence by major pathological type and ischemic subtypes in the Auckland regional community stroke studies: changes between 2002 and 2011. Stroke 2018;49:3–10. 10.1161/STROKEAHA.117.019358 [DOI] [PubMed] [Google Scholar]
  • 23.Tung Y-C, Chang G-M. The effect of cuts in reimbursement on stroke outcome: a nationwide population-based study during the period 1998 to 2007. Stroke 2010;41:504–9. 10.1161/STROKEAHA.109.568956 [DOI] [PubMed] [Google Scholar]
  • 24.Liu J, Shi L, Meng Q, et al. Income-Related inequality in health insurance coverage: analysis of China health and nutrition survey of 2006 and 2009. Int J Equity Health 2012;11:42. 10.1186/1475-9276-11-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wang Y, Cui L, Ji X, et al. The China national stroke Registry for patients with acute cerebrovascular events: design, rationale, and baseline patient characteristics. Int J Stroke 2011;6:355–61. 10.1111/j.1747-4949.2011.00584.x [DOI] [PubMed] [Google Scholar]
  • 26.Zhang C, Lei X, Strauss J, et al. Health insurance and health care among the mid-aged and older Chinese: evidence from the National baseline survey of CHARLS. Health Econ 2017;26:431–49. 10.1002/hec.3322 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kaso M, Takahashi Y, Nakayama T. Factors related to cervical cancer screening among women of childrearing age: a cross-sectional study of a nationally representative sample in Japan. Int J Clin Oncol 2019;24:1–10. 10.1007/s10147-018-1350-z [DOI] [PubMed] [Google Scholar]
  • 28.Manwani B, Rath S, Lee NS, et al. Early magnetic resonance imaging decreases hospital length of stay in patients with ischemic stroke. J Stroke Cerebrovasc Dis 2019;28:425–9. 10.1016/j.jstrokecerebrovasdis.2018.10.015 [DOI] [PubMed] [Google Scholar]
  • 29.Kato N, Kondo M, Okubo I, et al. Length of hospital stay in Japan 1971-2008: hospital ownership and cost-containment policies. Health Policy 2014;115:180–8. 10.1016/j.healthpol.2014.01.002 [DOI] [PubMed] [Google Scholar]
  • 30.Lee H-C, Chang K-C, Huang Y-C, et al. Inpatient rehabilitation utilization for acute stroke under a universal health insurance system. Am J Manag Care 2010;16:e67–74. [PubMed] [Google Scholar]
  • 31.Fargen KM, Neal D, Blackburn SL, et al. Health disparities and stroke: the influence of insurance status on the prevalence of patient safety indicators and hospital-acquired conditions. J Neurosurg 2015;122:870–5. 10.3171/2014.12.JNS14646 [DOI] [PubMed] [Google Scholar]
  • 32.Ma Y, Liu Y, Fu H-M, et al. Evaluation of admission characteristics, hospital length of stay and costs for cerebral infarction in a medium-sized City in China. Eur J Neurol 2010;17:1270–6. 10.1111/j.1468-1331.2010.03007.x [DOI] [PubMed] [Google Scholar]
  • 33.Lin X, Cai M, Tao H, et al. Insurance status, inhospital mortality and length of stay in hospitalised patients in Shanxi, China: a cross-sectional study. BMJ Open 2017;7:e015884. 10.1136/bmjopen-2017-015884 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Yong M, Xianjun X, Jinghu L, et al. Effect of health insurance on direct hospitalisation costs for in-patients with ischaemic stroke in China. Aust Health Rev 2018;42:39–44. 10.1071/AH16056 [DOI] [PubMed] [Google Scholar]
  • 35.Medford-Davis LN, Fonarow GC, Bhatt DL, et al. Impact of insurance status on outcomes and use of rehabilitation services in acute ischemic stroke: findings from get with the Guidelines-Stroke. J Am Heart Assoc 2016;5:e004282. 10.1161/JAHA.116.004282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Yu J, Qiu Y, He Z. Is universal and uniform health insurance better for China? Evidence from the perspective of supply-induced demand. Health Econ Policy Law 2020;15:1–16. 10.1017/S1744133118000385 [DOI] [PubMed] [Google Scholar]
  • 37.Meng Q, Xu L, Zhang Y, et al. Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study. Lancet 2012;379:805–14. 10.1016/S0140-6736(12)60278-5 [DOI] [PubMed] [Google Scholar]
  • 38.Heeley E, Anderson CS, Huang Y, et al. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke 2009;40:2149–56. 10.1161/STROKEAHA.108.540054 [DOI] [PubMed] [Google Scholar]
  • 39.Husaini B, Levine R, Sharp L, et al. Depression increases stroke hospitalization cost: an analysis of 17,010 stroke patients in 2008 by race and gender. Stroke Res Treat 2013;2013:846732. 10.1155/2013/846732 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wen L, Wu J, Feng L, et al. Comparing the economic burden of ischemic stroke patients with and without atrial fibrillation: a retrospective study in Beijing, China. Curr Med Res Opin 2017;33:1789–94. 10.1080/03007995.2017.1348345 [DOI] [PubMed] [Google Scholar]
  • 41.Wang G, Zhang Z, Ayala C, et al. Costs of hospitalization for stroke patients aged 18-64 years in the United States. J Stroke Cerebrovasc Dis 2014;23:861–8. 10.1016/j.jstrokecerebrovasdis.2013.07.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Brinjikji W, Kallmes DF, Rabinstein AA, et al. Hospitalization costs for patients with acute ischemic stroke treated with endovascular embolectomy in the United States. Stroke 2011;42:3271–3. 10.1161/STROKEAHA.111.618405 [DOI] [PubMed] [Google Scholar]
  • 43.Gupta R, Islam S, Mony P, et al. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: the pure study. Eur J Prev Cardiol 2015;22:1261–71. 10.1177/2047487314540386 [DOI] [PubMed] [Google Scholar]
  • 44.Venketasubramanian N, Yin A. Hospital costs for stroke care in Singapore. Cerebrovasc Dis 2000;10:320–6. 10.1159/000016077 [DOI] [PubMed] [Google Scholar]
  • 45.Chang K-C, Tseng M-C. Costs of acute care of first-ever ischemic stroke in Taiwan. Stroke 2003;34:e219–21. 10.1161/01.STR.0000095565.12945.18 [DOI] [PubMed] [Google Scholar]
  • 46.Security TBBoHRaS Detailed rules for the implementation of basic medical insurance for urban and rural residents in Beijing, 2017. Available: http://www.bjrbj.gov.cn/xxgk/zcfg/201712/t20171213_69593.html
  • 47.Changmin T, Xiao F, Xiao Y, et al. Analysis on necessity and feasible path of the integration of medical insurance system for residents in urban and Ru⁃ral areas. Chinese Health Economics 2016;35:38–40. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Reviewer comments
Author's manuscript

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES